CYP2D6 allele frequencies in Korean population, comparison with East Asian, Caucasian and African populations, and the comparison of metabolic activity of CYP2D6 genotypes

Analysis of Genetic Variation in CYP450 Genes for Clinical Implementation

(2017) Liuh Ling Goh et al.   PLoS One

High Frequency ofCYP2D6Ultrarapid Metabolizer Genotype in the Finnish Population

(2016) Paavo Pietarinen et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Prediction of CYP2D6 phenotype from genotype across world populations

(2016) Andrea Gaedigk et al.   GENETICS IN MEDICINE

The Importance of Patient-Specific Factors for Hepatic Drug Response and Toxicity

(2016) Volker Lauschke et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Pharmacogenetics of Cytochrome P450 Enzymes in American Indian and Caucasian Children Admitted to a Psychiatric Hospital

(2016) Ian R. McGrane et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

DNA Microarray Technology in the Clinical Environment: The AmpliChip CYP450 Test for CYP2D6 and CYP2C19 Genotyping

(2016) Jose de Leon et al.   CNS SPECTRUMS

Effects of the CYP2D6*10 allele on the pharmacokinetics of atomoxetine and its metabolites

(2015) Ji-Yeong Byeon et al.   ARCHIVES OF PHARMACAL RESEARCH

Combination Analysis in Genetic Polymorphisms of Drug-Metabolizing Enzymes CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A5 in the Japanese Population

(2015) Tomoko Ota et al.   International Journal of Medical Sciences

Interethnic variation of CYP2C19 alleles, ‘predicted’ phenotypes and ‘measured’ metabolic phenotypes across world populations

(2015) I Fricke-Galindo et al.   PHARMACOGENOMICS JOURNAL

Challenges in CYP2D6 Phenotype Assignment from Genotype Data: A Critical Assessment and Call for Standardization

(2014) J. Hicks et al.   CURRENT DRUG METABOLISM

Interethnic variability ofCYP2D6alleles and of predicted and measured metabolic phenotypes across world populations

(2014) Adrián LLerena et al.   Expert Opinion on Drug Metabolism & Toxicology

Cytochrome P450 2D6 Polymorphisms and Predicted Opioid Metabolism in African American Children With Sickle Cell Disease

(2013) Marianne M. Yee et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Lack of any association between functionally significant CYP2D6 polymorphisms and clinical outcomes in early breast cancer patients receiving adjuvant tamoxifen treatment

(2011) In Hae Park et al.   BREAST CANCER RESEARCH AND TREATMENT

Association between Genetic Polymorphisms of CYP2D6 and Outcomes in Breast Cancer Patients with Tamoxifen Treatment

(2011) Hyung Seok Park et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Genetic Variation in Metabolizing Enzyme and Transporter Genes: Comprehensive Assessment in 3 Major East Asian Subpopulations With Comparison to Caucasians and Africans

(2010) Michael Man et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Recognition of Impaired Atomoxetine Metabolism Because of Low CYP2D6 Activity

(2010) Maureen A. ter Laak et al.   PEDIATRIC NEUROLOGY

CYP2D6 Genotyping for Functional-Gene Dosage Analysis by Allele Copy Number Detection

(2009) N. Hosono et al.   CLINICAL CHEMISTRY

Discovery of Novel Functional Variants and Extensive Evaluation of CYP2D6 Genetic Polymorphisms in Koreans

(2009) S.-J. Lee et al.   DRUG METABOLISM AND DISPOSITION

Relationship of CYP2D6 genetic polymorphisms and the pharmacokinetics of tramadol in Chinese volunteers

(2009) Q. Li et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Cytochrome P450 2D6

(2009) Ryan P. Owen et al.   Pharmacogenetics and Genomics

Genetic polymorphism, linkage disequilibrium, haplotype structure and novel allele analysis of CYP2C19 and CYP2D6 in Han Chinese

(2009) Q Zhou et al.   PHARMACOGENOMICS JOURNAL

Systematic polymorphism analysis of the CYP2D6 gene in four different geographical Han populations in mainland China

(2008) Shengying Qin et al.   GENOMICS

Influence ofCYP2D6*10on the pharmacokinetics of metoprolol in healthy Korean volunteers

(2008) S. K. Jin et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS